Загрузка...
Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation...
Сохранить в:
| Опубликовано в: : | J Saudi Heart Assoc |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6035384/ https://ncbi.nlm.nih.gov/pubmed/29989026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsha.2017.12.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|